Legal & General Group PLC Paratek Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.73 - $3.09 $8,611 - $15,382	-4,978 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $726 - $1,178	247 Added 5.22%	4,978 $15,000
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $1,811 - $2,451	-295 Reduced 5.87%	4,731 $33,000
Q3 2020 Nov 13, 2020	SELL	$4.19 - $6.69 $6,674 - $10,657	-1,593 Reduced 24.07%	5,026 $27,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $4,437 - $7,798	1,494 Added 29.15%	6,619 $35,000
Q1 2020 May 14, 2020	SELL	$2.67 - $4.97 $1,946 - $3,623	-729 Reduced 12.45%	5,125 $16,000
Q4 2019 Feb 13, 2020	BUY	$2.93 - $4.5 $3,372 - $5,179	1,151 Added 24.47%	5,854 $24,000
Q2 2018 Aug 10, 2018	SELL	$10.2 - $13.9 $71 - $97	-7 Reduced 0.15%	4,703 $48,000
Q1 2018 May 17, 2018	SELL	$12.65 - $18.85 $14,914 - $22,224	-1,179 Reduced 20.02%	4,710 $61,000
Q4 2017 Feb 13, 2018	BUY	$17.45 - $25.6 $102,763 - $150,758	5,889	5,889 $106,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.